Rodos BioTarget
Developing a targeted drug delivery platform, TargoSphere®.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD5—8m (Dealroom.co estimates Aug 2017.)
Company register number HRB 203405 (Hannover)
Hanover Lower Saxony (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2018 | 2019 |
|---|---|---|---|---|
| Revenues | 1.1m | <1m | - | - |
| % growth | - | (92 %) | - | - |
| EBITDA | - | - | - | (<1m) |
| Profit | - | - | (<1m) | (<1m) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
N/A | Early VC | ||
N/A | Seed | ||
| N/A | N/A | Seed | |
* | €800k | Seed | |
| Total Funding | AUD1.4m | ||
Related Content
Recent News about Rodos BioTarget
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.